Clinical Trial Update: Oral Cannabidiol for Opioid Withdrawal [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating oral cannabidiol for opioid withdrawal and craving has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Craving
• Opioid Use Disorder
• Opioid Withdrawal

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Johns Hopkins University | Conditions: Opioid Withdrawal, Opioid Craving | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-08-29